Literature DB >> 15161898

Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.

Scott C Howard1, Marcia Pedrosa, Mecneide Lins, Arli Pedrosa, Ching-Hon Pui, Raul C Ribeiro, Francisco Pedrosa.   

Abstract

CONTEXT: The cure rate for childhood acute lymphoblastic leukemia (ALL) differs markedly between developed and developing countries.
OBJECTIVE: To assess the effect of a multidisciplinary team approach and protocol-based therapy on the event-free survival of children with ALL in an area with limited resources. DESIGN, POPULATION, AND
SETTING: A retrospective cohort study at a pediatric hospital in the resource-poor city of Recife, Brazil. We reviewed medical records of the outcomes of 375 children with ALL diagnosed between 1980 and 2002. Eighty-three children were diagnosed in the early period (1980-1989), in the absence of a dedicated pediatric oncology unit, protocol-based therapy, specially trained nurses, 24-hour on-site physician coverage, and ready access to intensive care. Seventy-eight children were treated (all according to protocol) during the middle period (July 1994 to March 1997). During the recent period (April 1997 to December 2002), 214 children were treated with protocol in a dedicated pediatric oncology unit staffed 24 hours by pediatric oncologists and oncology nurses. Improvements were implemented gradually during the middle period and were completed during the recent period. MAIN OUTCOME MEASURE: Event-free survival was estimated by the Kaplan-Meier method. Events included death from toxicity, disease progression or relapse, and abandonment of treatment.
RESULTS: The 5-year event-free survival improved steadily: 32% (95% CI, 21%-43%) in the early period, 47% (95% CI, 36%-58%) in the middle period, and 63% (95% CI, 55%-71%) in the recent period. The probability of cause-specific treatment failure in the early, middle, and late periods, respectively, within 1 year of diagnosis was 14% vs 3.8% vs 3.3% for relapse; 6.0% vs 12% vs 9.8% for death from infection; 2.4% vs 13% vs 4.2% for death from noninfectious toxicity; and 16% vs 1.3% vs 0.5% for abandonment of therapy.
CONCLUSION: Treatment of childhood ALL in a dedicated pediatric oncology unit using a comprehensive multidisciplinary team approach, protocol-based therapy, and local support and funding is associated with improved outcomes in a resource-poor area.

Entities:  

Mesh:

Year:  2004        PMID: 15161898     DOI: 10.1001/jama.291.20.2471

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  52 in total

1.  Care of pediatric cancers in the developing world: should this be a societal priority?

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

2.  Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study.

Authors:  Raul C Ribeiro; Eva Steliarova-Foucher; Ian Magrath; Jean Lemerle; Tim Eden; Caty Forget; Isabel Mortara; Isabelle Tabah-Fisch; Jose Julio Divino; Thomas Miklavec; Scott C Howard; Franco Cavalli
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

3.  Incidence and consequences of varicella in children treated for cancer in Guatemala.

Authors:  Amy E Caruso Brown; Edwin J Asturias; Mario Melgar; Federico A Antillon-Klussmann; Pamela Mettler; Myron J Levin
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

4.  Factors influencing time to diagnosis of childhood cancer in Ibadan, Nigeria.

Authors:  B J Brown; B O James; S O Ajayi; O A Ogun; R E Oladokun
Journal:  Afr Health Sci       Date:  2009-12       Impact factor: 0.927

5.  Teleoncology: current and future applications for improving cancer care globally.

Authors:  Ribhi Hazin; Ibrahim Qaddoumi
Journal:  Lancet Oncol       Date:  2010-02       Impact factor: 41.316

6.  Improving diagnosis and treatment of acute childhood leukemia in Uganda: impact of flow cytometry.

Authors:  Ruth Namazzi; Amos Gaikwad; Peter Wasswa; Michael Cubbage; Joyce B Kambugu; Philip Kasirye; Fadhil Geriga; Carl Allen; Joseph Lubega
Journal:  Blood Adv       Date:  2018-11-30

Review 7.  Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries.

Authors:  Raul C Ribeiro; Federico Antillon; Francisco Pedrosa; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

8.  A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome.

Authors:  Elaine Coustan-Smith; Raul C Ribeiro; Patricia Stow; Yinmei Zhou; Ching-Hon Pui; Gaston K Rivera; Francisco Pedrosa; Dario Campana
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  Geographic and ethnic differences in childhood leukaemia and lymphoma survival: comparisons of Philippine residents, Asian Americans and Caucasians in the United States.

Authors:  M T Redaniel; A Laudico; M R Mirasol-Lumague; A P Alcasabas; D Pulte; H Brenner
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

10.  Characterization of acute lymphoblastic leukemia subtypes in moroccan children.

Authors:  Fatima Bachir; Sanae Bennani; Ali Lahjouji; Siham Cherkaoui; M'hamed Harif; Mohamed Khattab; Ilham Nassereddine; Saadia Zafad; Rajae El Aouad
Journal:  Int J Pediatr       Date:  2009-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.